Literature DB >> 23192629

Long-Term immune responses to Coxiella burnetii after vaccination.

Gilbert J Kersh1, Kelly A Fitzpatrick, Joshua S Self, Brad J Biggerstaff, Robert F Massung.   

Abstract

Q fever is a zoonotic disease caused by infection with the bacterium Coxiella burnetii. Infection with C. burnetii results in humoral and cellular immune responses, both of which are thought to contribute to protection against subsequent infection. Whole-cell formalin-inactivated vaccines have also been shown to induce both humoral and cellular immunity and provide protection. Whether measurement of cellular or humoral immunity is a better indicator of immune protection is not known, and the duration of immunity induced by natural infection or vaccination is also poorly understood. To better understand the measurement and duration of C. burnetii immunity, 16 people vaccinated against Q fever (0.2 to 10.3 years before analysis) and 29 controls with a low risk of Q fever exposure were tested for immune responses to C. burnetii by an indirect fluorescent-antibody test (IFA) to measure circulating antibody and by a gamma interferon release assay (IGRA) to measure cellular immunity. Among vaccinated subjects, the IFA detected antibodies in 13/16, and the IGRA also detected positive responses in 13/16. All of the vaccinated subjects had a positive response in at least one of the assays, whereas 8/29 control subjects were positive in at least one assay. There was not a correlation between time since vaccination and responses in these assays. These results show that IFA and IGRA perform similarly in detection of C. burnetii immune responses and that Q fever vaccination establishes long-lived immune responses to C. burnetii.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192629      PMCID: PMC3571276          DOI: 10.1128/CVI.00613-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  22 in total

Review 1.  A review of the efficacy of human Q fever vaccine registered in Australia.

Authors:  Clayton K Chiu; David N Durrheim
Journal:  N S W Public Health Bull       Date:  2007 Jul-Aug

2.  Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection.

Authors:  G H Mazurek; P A LoBue; C L Daley; J Bernardo; A A Lardizabal; W R Bishai; M F Iademarco; J S Rothel
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

3.  Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice.

Authors:  J C Williams; J L Cantrell
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

Review 4.  Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.

Authors:  J C Williams; M G Peacock; D M Waag; G Kent; M J England; G Nelson; E H Stephenson
Journal:  Ann N Y Acad Sci       Date:  1992-06-16       Impact factor: 5.691

Review 5.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

6.  Detection of long-term cellular immunity to Coxiella burneti as assayed by lymphocyte transformation.

Authors:  T R Jerrells; L P Mallavia; D J Hinrichs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

7.  Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects.

Authors:  A A Izzo; B P Marmion
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

8.  Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.

Authors:  B P Marmion; R A Ormsbee; M Kyrkou; J Wright; D A Worswick; A A Izzo; A Esterman; B Feery; R A Shapiro
Journal:  Epidemiol Infect       Date:  1990-04       Impact factor: 2.451

9.  Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice.

Authors:  Guoquan Zhang; Kasi E Russell-Lodrigue; Masako Andoh; Yan Zhang; Laura R Hendrix; James E Samuel
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

10.  Time-course of antibody responses against Coxiella burnetii following acute Q fever.

Authors:  P F M Teunis; B Schimmer; D W Notermans; A C A P Leenders; P C Wever; M E E Kretzschmar; P M Schneeberger
Journal:  Epidemiol Infect       Date:  2012-04-04       Impact factor: 4.434

View more
  14 in total

1.  Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.

Authors:  Chen Chen; Erin J van Schaik; Anthony E Gregory; Adam Vigil; Phillip L Felgner; Laura R Hendrix; Robert Faris; James E Samuel
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

2.  Survey of laboratory animal technicians in the United States for Coxiella burnetii antibodies and exploration of risk factors for exposure.

Authors:  Ellen A Spotts Whitney; Robert F Massung; Gilbert J Kersh; Kelly A Fitzpatrick; Deborah M Mook; Douglas K Taylor; Michael J Huerkamp; Jessica C Vakili; Patrick J Sullivan; Ruth L Berkelman
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-11       Impact factor: 1.232

3.  Serological Evidence of Coxiella burnetii Infection in Cattle and Goats in Bangladesh.

Authors:  Najmul Haider; Md Shafiqur Rahman; Salah Uddin Khan; Andrea Mikolon; Muzaffor G Osmani; Emily S Gurley; Ireen Sultana Shanta; Suman Kumer Paul; Laura Macfarlane-Berry; Ariful Islam; Ausraful Islam; James Desmond; Jonathan H Epstein; Rachael A Priestley; Gilbert J Kersh; Mohammed Ziaur Rahman; Peter Daszak; Stephen P Luby; Robert F Massung; Nord Zeidner
Journal:  Ecohealth       Date:  2015-02-04       Impact factor: 3.184

4.  Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

5.  Prevalence and risk factors for Coxiella burnetii seropositivity in small ruminant veterinarians and veterinary students in Ontario, Canada.

Authors:  Shannon L Meadows; Andria Jones-Bitton; Scott A McEwen; Jocelyn Jansen; Samir N Patel; Catherine Filejski; Paula Menzies
Journal:  Can Vet J       Date:  2017-04       Impact factor: 1.008

6.  Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice.

Authors:  Teske Schoffelen; Joshua S Self; Kelly A Fitzpatrick; Mihai G Netea; Marcel van Deuren; Leo A B Joosten; Gilbert J Kersh
Journal:  Diagn Microbiol Infect Dis       Date:  2014-12-30       Impact factor: 2.803

7.  Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii.

Authors:  Susan Raju Paul; Anja Scholzen; Ghazel Mukhtar; Stephanie Wilkinson; Peter Hobson; Richard K Dzeng; Jennifer Evans; Jennifer Robson; Rowland Cobbold; Stephen Graves; Mark C Poznansky; Anja Garritsen; Ann E Sluder
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

8.  Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.

Authors:  A E Gregory; E J van Schaik; K E Russell-Lodrigue; A P Fratzke; J E Samuel
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

9.  Vaccination against Q fever for biodefense and public health indications.

Authors:  Sara Ruiz; Daniel N Wolfe
Journal:  Front Microbiol       Date:  2014-12-16       Impact factor: 5.640

10.  Seroprevlance of Coxiella burnetii among abattoir and slaughterhouse workers: A meta-analysis.

Authors:  Solomon M Woldeyohannes; Charles F Gilks; Peter Baker; Nigel R Perkins; Simon A Reid
Journal:  One Health       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.